High Pressure Contrast Media Injectors Market (2024 - 2030)

Market Size & Trends

The global high pressure contrast media injectors market size was valued at USD 254.1 million in 2023 and is anticipated to grow at a CAGR of 7.7% from 2024 to 2030.The need for high pressure contrast media injectors will be high due to the rising prevalence of chronic illnesses such as cancer, neurovascular disease, and cardiovascular diseases in the forecast period. High pressure contrast media injectors have shifted from manual injectors with stop-cocks to automated ones as a result of cutting-edge technology.

The cutting-edge technology with conventional high pressure contrast media injectors drives the market development. This includes high pressure automated injectors and syringeless injectors with IT support. Syringeless power injectors have become increasingly popular to minimize contrast media residues in the past few years. Furthermore, syringeless injectors optimize patient turnover as they offer high feasibility for complex procedures in the healthcare domain. However, the market growth is limited due to the premium cost of high pressure contrast media injectors, consumables, and accessories.

Manufacturers of high pressure contrast media injectors are concentrating on the creation of intelligent devices to reduce the likelihood of human error as artificial intelligence permeates the healthcare sector. Modern interface systems, including the Picture Archive and Communication System (PACS) and the Radiology Information System (RIS), help gather patient data and deliver the right contrast dosage.

Product Insights

In 2023, the consumables segment held the largest share of 60.3%. The high utilization of disposable devices due to their high level of safety and features such as ease of use, high efficiency, and minimal waste generation can be credited for the segment's quick rise. Syringes, tubings, and other items are further categorized under consumables. The consumables are essential for surgical procedures and contribute to the clinical outcome.

The injector systems are expected to witness a steady CAGR of 8.2% in the forecast period. Increased use of advanced imaging technologies, often requiring more specific or detailed applications, drives revenue growth in the consumables sector. Regular maintenance and replacement of consumables are necessary for operation and protection against high-pressure injection molding. This drives a high demand for consumables. Larger healthcare facilities and imaging centers purchase consumables to handle the volume of procedures performed.

Type Insights

The single head segment dominated the market and accounted for the largest revenue share in 2023.After angiography, CT and MRI are the most often used applications. Furthermore, the low cost of these devices over other systems are anticipated to drive demand in economies such as China, India, and Brazil. It is also expected that this market will grow due to the introduction of numerous new goods.

The dual head injector segment is poised to witness a fast CAGR in the forecast period. This is attributed to the benefits, which include controlled distribution and quicker operations. Modern contrast injection systems incorporate improvements to streamline workflow, control injector protocol data, and promote patient safety.

Application Insights

The interventional cardiology segment dominated the market for high pressure contrast media injectors and accounted for the largest revenue share of 35.3% in 2023. The need for interventional cardiac surgery has increased due to a sharp increase in the occurrence of cardiovascular issues, both for diagnosis and treatment. As a result, rising demand for innovative products with high precision and efficiency is anticipated to drive market expansion during the forecast period.

Interventional radiology is expected to grow significantly in the forecast period. It is largely used to diagnose a wide range of ailments, including cardiovascular diseases, cancer, fractured bones, gastrointestinal issues, and blood clots. Technological developments and a rise in the demand for non-invasive medical imaging techniques have also contributed to the segment's growth.

End Use Insights

The hospitals segment dominated the market and held the largest revenue share of 61.5% in 2023.Throughout the forecast period, the rise in the number of hospitalized patients suffering from cardiovascular, neurological, and cancer disorders. High pressure contrast media injectors finds potent applications in hospitals for radiology, interventional radiology, and interventional cardiology.The growth of this segment can be attributed to the increasing number of diagnostic imaging procedures in hospitals. The growing adoption of minimally invasive procedures (including diagnostic imaging systems) in hospitals enhances the quality of patient care.

The diagnostic centers' is anticipated to experience significant expansion during the forecast period. The rise in chronic diseases such as cancer, neurological conditions, and neurodegenerative diseases demands a robust healthcare infrastructure. Increased demand for CT and MRI treatments are used for diagnosis, therapies, and prevent any chronic illnesses. A wide range of diagnostic and preventive healthcare services are offered by these diagnostic centers.

Regional Insights

North America High Pressure Contrast Media Injectors market dominated global industry and accounted for the largest revenue share of 38.1% in 2023. The market is driven by the swift uptake of traditional technologies, improved healthcare infrastructure, robust purchasing power, and an equitable reimbursement structure. The need for high pressure contrast media injectors is anticipated to grow due to factors, including an increase in cases of trauma and accident, cancer prevalence, cardiovascular and neurological diseases, insurance coverage availability, and the need for contrast studies.

Europe High Pressure Contrast Media Injectors Market Trends

Europe high pressure contrast media injectors market is expected to witness a fast-growing CAGR of 7.8% in the forecast period. Europe has a robust healthcare system with advanced hospitals and infectious disease centers. These centers typically use high-pressure grinding machines to perform high-quality imaging techniques, which drives the adoption of high-pressure injectors in the region. The ongoing development and modernization of healthcare facilities across Europe is driving the development of advanced diagnostic equipment on demand, including high pressure contrast injection machines. The European market has a high use of advanced imaging technologies such as CT and MRI. High pressure contrast injectors are needed for the clarity and accuracy of these imaging techniques.

Asia Pacific High Pressure Contrast Media Injectors Market Trends

Asia Pacific accounted for a market share of 25.0% in 2023. The growth is anticipated to be fueled by the increasing prevalence of long-term illnesses such as cancer, orthopedic problems, epilepsy, and cardiovascular disease. Rapid population growth and urbanization are increasing the need for healthcare. The urban areas witness a surge in demand for diagnostic imaging, leading to the use of advanced sophisticated injection equipment during the forecast period.

Key High Pressure Contrast Media Injectors Company Insights

Some key players in the high pressure contrast media injectors market are MEDTRON AG, Bracco Group, GE Healthcare, and others. Market participants are involved in several strategic efforts, such as partnerships, collaborations, mergers, acquisitions, and new product development.For example, Bayer Radiology introduced Radimetrics v3.0. It helps manage radiation and contrast exposure across the chain of care with enhanced features and capabilities.

• MEDTRON AG is a leading European manufacturer of contrast media injectors used for medical imaging such as CT scans, MRIs, and angiography. The company’s flagship Accutron injectors are known for being innovative, user-friendly, and cost-effective. They are committed to developing high-quality products that improve diagnostics for patients around the world.

• Bracco, a diagnostic imaging company, offers a wide range of contrast agents and solutions. The company focuses on X-ray, CT, MRI, and nuclear medicine, helping medical professionals see clearer for better diagnoses. Their commitment to research and development ensures they're constantly innovating to improve patient care.

Recent Developments

• In January 2024, Indian Institute of Sciences (IISc) signed MoU with Wipro GE Healthcare to serve and excel in medtech innovation for India and global healthcare

• In February 2024, NUCLIDIUM and Guerbet formed strategic partnership to support the advancement of targeted copper-based radiotheranostics.

High Pressure Contrast Media Injectors Market